These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 30419728)
1. Virus-Like Particles Expressing Toxoplasma gondii Rhoptry Protein 18 Induces Better Protection Than Rhoptry Protein 4 against T. gondii Infection. Kang HJ; Lee SH; Chu KB; Lee DH; Quan FS Korean J Parasitol; 2018 Oct; 56(5):429-435. PubMed ID: 30419728 [TBL] [Abstract][Full Text] [Related]
2. Virus-like particle vaccines expressing Toxoplasma gondii rhoptry protein 18 and microneme protein 8 provide enhanced protection. Lee SH; Kang HJ; Lee DH; Kang SM; Quan FS Vaccine; 2018 Sep; 36(38):5692-5700. PubMed ID: 30107996 [TBL] [Abstract][Full Text] [Related]
3. Virus-like Particle Vaccine Containing Toxoplasma gondii Rhoptry Protein 13 Induces Protection against T. gondii ME49 Infection in Mice. Kang HJ; Chu KB; Lee SH; Kim MJ; Park H; Jin H; Quan FS Korean J Parasitol; 2019 Oct; 57(5):543-547. PubMed ID: 31715698 [TBL] [Abstract][Full Text] [Related]
4. Toxoplasma gondii virus-like particle vaccination alleviates inflammatory response in the brain upon T gondii infection. Kang HJ; Chu KB; Lee SH; Kim MJ; Park H; Jin H; Moon EK; Quan FS Parasite Immunol; 2020 Jun; 42(6):e12716. PubMed ID: 32249951 [TBL] [Abstract][Full Text] [Related]
5. Protective Immunity Induced by Incorporating Multiple Antigenic Proteins of Lee SH; Kang HJ; Lee DH; Quan FS Front Immunol; 2018; 9():3073. PubMed ID: 30666253 [TBL] [Abstract][Full Text] [Related]
6. Virus-like particles containing multiple antigenic proteins of Toxoplasma gondii induce memory T cell and B cell responses. Lee SH; Chu KB; Kang HJ; Quan FS PLoS One; 2019; 14(8):e0220865. PubMed ID: 31465461 [TBL] [Abstract][Full Text] [Related]
7. Influenza M1 Virus-Like Particles Consisting of Lee SH; Lee DH; Piao Y; Moon EK; Quan FS Korean J Parasitol; 2017 Apr; 55(2):143-148. PubMed ID: 28506036 [No Abstract] [Full Text] [Related]
8. Evaluation of immune responses induced by rhoptry protein 5 and rhoptry protein 7 DNA vaccines against Toxoplasma gondii. Wang L; Lu G; Zhou A; Han Y; Guo J; Zhou H; Cong H; He S Parasite Immunol; 2016 Apr; 38(4):209-17. PubMed ID: 26802673 [TBL] [Abstract][Full Text] [Related]
9. Influenza Virus-Like Particles Presenting both Kang HJ; Lee SH; Kim MJ; Chu KB; Lee DH; Chopra M; Choi HJ; Park H; Jin H; Quan FS Pharmaceutics; 2019 Jul; 11(7):. PubMed ID: 31315212 [TBL] [Abstract][Full Text] [Related]
10. Mucosal Administration of Recombinant Baculovirus Displaying Yoon KW; Chu KB; Kang HJ; Kim MJ; Eom GD; Lee SH; Moon EK; Quan FS Front Cell Infect Microbiol; 2021; 11():735191. PubMed ID: 34660343 [TBL] [Abstract][Full Text] [Related]
11. Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis. Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Dlugonska H Exp Parasitol; 2009 Sep; 123(1):81-9. PubMed ID: 19508869 [TBL] [Abstract][Full Text] [Related]
12. Protective immunity induced by CpG ODN-adjuvanted virus-like particles containing Toxoplasma gondii proteins. Kang HJ; Chu KB; Kim MJ; Lee SH; Park H; Jin H; Moon EK; Quan FS Parasite Immunol; 2021 Jan; 43(1):e12799. PubMed ID: 33058167 [TBL] [Abstract][Full Text] [Related]
13. Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice. Dziadek B; Gatkowska J; Grzybowski M; Dziadek J; Dzitko K; Dlugonska H Exp Parasitol; 2012 May; 131(1):133-8. PubMed ID: 22445587 [TBL] [Abstract][Full Text] [Related]
14. Detection of Toxoplasma gondii Infections using Virus-Like Particles Displaying T. gondii ROP4 Antigen. Kim MJ; Mao J; Kang HJ; Chu KB; Quan FS Korean J Parasitol; 2021 Dec; 59(6):565-572. PubMed ID: 34974663 [TBL] [Abstract][Full Text] [Related]
15. Protection induced by virus-like particles containing Toxoplasma gondii microneme protein 8 against highly virulent RH strain of Toxoplasma gondii infection. Lee SH; Kim AR; Lee DH; Rubino I; Choi HJ; Quan FS PLoS One; 2017; 12(4):e0175644. PubMed ID: 28406951 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of the protective efficacy of a ROP18 vaccine against chronic toxoplasmosis by nasal route. Rashid I; Moiré N; Héraut B; Dimier-Poisson I; Mévélec MN Med Microbiol Immunol; 2017 Feb; 206(1):53-62. PubMed ID: 27757545 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis. Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690 [TBL] [Abstract][Full Text] [Related]
18. Protective mucosal and systemic immunity induced by virus-like particles expressing Toxoplasma gondii cyst wall protein. Eom GD; Chu KB; Kang HJ; Kim MJ; Yoon KW; Mao J; Lee SH; Ahmed MA; Moon EK; Quan FS PLoS One; 2023; 18(4):e0283928. PubMed ID: 37104285 [TBL] [Abstract][Full Text] [Related]
19. Cross-protection induced by Toxoplasma gondii virus-like particle vaccine upon intraperitoneal route challenge. Lee DH; Kim AR; Lee SH; Quan FS Acta Trop; 2016 Dec; 164():77-83. PubMed ID: 27586039 [TBL] [Abstract][Full Text] [Related]
20. A long-lasting protective immunity against chronic toxoplasmosis in mice induced by recombinant rhoptry proteins encapsulated in poly (lactide-co-glycolide) microparticles. Xu Y; Zhang NZ; Wang M; Dong H; Feng SY; Guo HC; Zhu XQ Parasitol Res; 2015 Nov; 114(11):4195-203. PubMed ID: 26243574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]